ArticleMolecules (Basel, Switzerland)2017

The Design and Evaluation of an l-Dopa-Lazabemide Prodrug for the Treatment of Parkinson's Disease.

Monique Hoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.